These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 404805)

  • 1. [Immunochemical study of serum in the diagnosis of mu-chain disease].
    Chernokhvostova EV; Batalova TN; Andreeva NE; Antipova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):42-8. PubMed ID: 404805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu heavy-chain disease--a defect in immunoglobulin assembly. Structural studies of the kappa chain.
    Frangione B; Franklin EC; Prelli F
    Scand J Immunol; 1976; 5(6-7):623-7. PubMed ID: 824712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
    Axelsen NH; Harboe M; Jonsson V; Videbaek AA
    Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and preparation of immunoglobulin (Ig) mu chain protein in sera of patients with heavy chain diseases (HCD).
    Wetter O; Drosdziok W; Müller B
    Klin Wochenschr; 1975 Sep; 53(18):885-6. PubMed ID: 809615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of paraprotein light chain type, identification of heavy chain disease.
    Backhausz R; Lajos J
    Immunochemistry; 1972 Oct; 9(10):1034-7. PubMed ID: 5086207
    [No Abstract]   [Full Text] [Related]  

  • 7. A new case of heavy mu-chain disease.
    Danon F; Mihaesco C; Bouvry M; Clerc M; Seligmann M
    Scand J Haematol; 1975 Aug; 15(1):5-9. PubMed ID: 170667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical aspects of the detection and characterization of immunoglobulin dyscrasis.
    Conway BP
    Health Lab Sci; 1972 Jul; 9(3):185-96. PubMed ID: 4625660
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicochemical and immunological properties of a mu chain disease protein.
    Mihaesco C; Mihaesco E; Miglierina R; Lamaziere J; Roy JP; Seligmann M
    Immunochemistry; 1976 Jan; 13(1):39-45. PubMed ID: 815173
    [No Abstract]   [Full Text] [Related]  

  • 10. Double paraprotein aemias (IgMK plus IgGK and IgGK plus BJL).
    Péter K; Ottó S
    Ann Immunol Hung; 1972; 16(0):319-27. PubMed ID: 4213040
    [No Abstract]   [Full Text] [Related]  

  • 11. The VKIIIb light chain sub-subgroup: restricted association with mu heavy chain in normal human serum.
    Moynihan JA; Looney RJ; Abraham GN
    Immunology; 1985 Feb; 54(2):207-13. PubMed ID: 3917972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
    Fujii H; Shimizu T; Seki S; Isemura T; Yamamoto K; Kanoh T; Ohno Y
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):622-32. PubMed ID: 6814143
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of several immunochemical approaches for the screening of alpha chain disease.
    Orr KB
    Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the light chain type of paraproteins, identification of heavy chain disease.
    Backhausz R; Lajos J
    Ann Immunol Hung; 1972; 16(0):43-50. PubMed ID: 4213025
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.
    Feremans W; Caudron M; Bieva C
    J Clin Pathol; 1979 Apr; 32(4):334-43. PubMed ID: 109474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-heavy chain disease. Preliminary studies in three cases.
    Ouchterlony O; Lindholm L; Lönnroth I; Westin J
    Ann Immunol Hung; 1972; 16(0):303-8. PubMed ID: 4137680
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulin disturbances and their clinical significance.
    Solomon A; McLaughlin CL
    Med Clin North Am; 1973 Mar; 57(2):499-516. PubMed ID: 4632920
    [No Abstract]   [Full Text] [Related]  

  • 18. Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies.
    Tracy RP; Kyle RA; Young DS
    Hum Pathol; 1984 Feb; 15(2):122-9. PubMed ID: 6421714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical and biochemical study of a human Fcmu-like fragment (mu-chain disease).
    Lebreton JP; Ropartz C; Rousseaus J; Roussel P; Dautrevaus M; Biserte G
    Eur J Immunol; 1975 Mar; 5(3):179-84. PubMed ID: 824130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bence Jones proteins: present diagnostic approaches.
    Ritzmann SE; Aguanno JJ; Finney MA; McCoy MT
    Lab Res Methods Biol Med; 1983; 8():147-71. PubMed ID: 6417425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.